Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Semaglutide, a GLP-1 receptor agonist , functions by reducing appetite and slowing gastric emptying, making it a valuable weight loss medication
Despite the SNAC shielding, absorption is only a small fraction of the injectable, so the dose is increased to make up the difference
Customer Focus: Your comfort and satisfaction are our top priorities
Obesity (Silver Spring, Md.), 19 (9), 17961803
The "Healthier on Ro" campaign was developed entirely by Ros in-house team, with production partner Young Hero, who also handled the initial launch
Key industry players Novo Nordisk, Eli Lilly, AstraZeneca and Sanofi lead the charge in GLP-1 drugs
US$ 21.23
US$ 21.08
US$ 23.33
US$ 26.25
US$ 26.38
US$ 27.82
US$ 23.97
US$ 28.94
